Science Explorer Back to mapMap
Discussion
Researcher · Oncode Institute · Netherlands

Dieuwke Louise Marvin

Dieuwke Louise Marvin publishes mostly in Molecular Biology, Oncology and Cancer Research, on topics such as Cancer Cells and Metastasis, TGF-β signaling in diseases and Cancer, Hypoxia, and Metabolism.

ORCID 0000-0001-6953-0489 OpenAlex
World rank
#1,944,470
of 7,710,434 ranked researchers
Rank in Netherlands
#42,510
of 107,149
Works
56
Citations
914
Citations per work
16.3
h-index
10
i10-index 10Top 76% in Molecular Biology
Dieuwke Louise Marvin

What does Dieuwke Louise Marvin research?

Dieuwke Louise Marvin's work is mostly in Biochemistry, Genetics and Molecular Biology (53%), Medicine (33%).

Life Sciences: 30 works · 53.4% of their workBiochemistry, Genetics and Molecular Biology: 30 works · 53.4% of their workMolecular Biology: 17 works · 31.0% of their workCancer Research: 10 works · 17.2% of their workCell Biology: 3 works · 5.2% of their workHealth Sciences: 18 works · 32.7% of their workMedicine: 18 works · 32.7% of their workOncology: 13 works · 24.1% of their workPulmonary and Respiratory Medicine: 3 works · 5.2% of their workImmunology and Allergy: 2 works · 3.4% of their workEverything else: 8 works · 13.9% of their workTHEIR WORKDieuwke LouiseMarvin56works
Life Sciences53%Health Sciences33%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology3053.4%
    1. Medicine1832.7%
  3. Everything else813.9%
  1. 1Molecular Biology31% of their works
  2. 2Oncology24% of their works
  3. 3Cancer Research17% of their works
  4. 4Cell Biology5% of their works
  5. 5Pulmonary and Respiratory Medicine5% of their works
  6. 6Immunology and Allergy3% of their works

Research topics

Which keywords describe Dieuwke Louise Marvin's research?

The keywords of their largest research topics: Metastasis, Cancer, Cancer Stem Cells, Tumor Metastasis, Smad-dependent pathways, Tumor Microenvironment, Tumor Suppression and Inflammation.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Metastasis92 topics
  2. Cancer73 topics
  3. Cancer Stem Cells71 topic
  4. Tumor Metastasis71 topic
  5. Smad-dependent pathways61 topic
  6. Tumor Microenvironment62 topics
  7. Tumor Suppression61 topic
  8. Inflammation52 topics
  9. Cell Death31 topic
  10. Ferroptosis31 topic
  11. HIF-131 topic
  12. Lymphangiogenesis31 topic
  13. VEGF-C31 topic
  14. Warburg Effect31 topic
  15. Cancer Genomics21 topic
  16. Fatty Acid Synthase21 topic
  17. Lipid Metabolism21 topic
  18. Mutational Signatures21 topic
  19. NF-?B21 topic
  20. Signaling21 topic

Where does Dieuwke Louise Marvin work?

Dieuwke Louise Marvin's main affiliation in the publication record is Oncode Institute, Netherlands.

How many publications and citations does Dieuwke Louise Marvin have?

OpenAlex counts 56 works and 914 citations for Dieuwke Louise Marvin, an h-index of 10, ranking #1,944,470 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Dieuwke Louise Marvin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.